Trial data revealed that antibodies generated by the vaccine interfered with HIV diagnosis and led to false positives on some HIV tests: Developers
The clinical trials of a coronavirus vaccine candidate being developed in Australia has been scrapped after trial participants returned false positive test results for HIV, the developers announced on Friday.The Covid-19 vaccine, which was being developed by the University of Queensland (UQ) and biotech firm CSL, have been scrapped, the company said in a statement released to the Australian Stock Exchange, CSL said it would halt the further trials.
The vaccine was one of four candidates that Australia had committed to buy and accordingly agreements were made to secure 51 million doses of the vaccine.
Stressing the vaccine had a “strong safety profile”, CSL said: “The potential for this cross-reaction had been anticipated prior to the commencement of the trial”.
In a statement, CSL said that no serious adverse effects had been reported in the 216 trial participants, and the vaccine was shown to have a “strong safety profile.”